151 related articles for article (PubMed ID: 30041188)
1. ONZIN Upregulation by Mutant p53 Contributes to Osteosarcoma Metastasis Through the CXCL5-MAPK Signaling Pathway.
Zhang Y; Hu Q; Li G; Li L; Liang S; Zhang Y; Liu J; Fan Z; Li L; Zhou B; Ruan Y; Yang X; Chen S; Mu T; Wang G; Xiong S
Cell Physiol Biochem; 2018; 48(3):1099-1111. PubMed ID: 30041188
[TBL] [Abstract][Full Text] [Related]
2. PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway.
Li L; Liang S; Wasylishen AR; Zhang Y; Yang X; Zhou B; Shan L; Han X; Mu T; Wang G; Xiong S
Oncotarget; 2016 Apr; 7(14):18021-35. PubMed ID: 26933804
[TBL] [Abstract][Full Text] [Related]
3. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
5. SLC25A22 Promotes Proliferation and Metastasis of Osteosarcoma Cells via the PTEN Signaling Pathway.
Chen MW; Wu XJ
Technol Cancer Res Treat; 2018 Jan; 17():1533033818811143. PubMed ID: 30482097
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.
Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A
Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111
[TBL] [Abstract][Full Text] [Related]
8. CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.
Tang Q; Lu J; Zou C; Shao Y; Chen Y; Narala S; Fang H; Xu H; Wang J; Shen J; Khokha R
Oncogene; 2018 Jul; 37(27):3617-3630. PubMed ID: 29610525
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA GClnc1 promotes tumorigenesis in osteosarcoma by inhibiting p53 signaling.
Sui Y; Han Y; Zhao X; Li D; Li G
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):36-42. PubMed ID: 30454890
[TBL] [Abstract][Full Text] [Related]
11. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53.
Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X
Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611
[TBL] [Abstract][Full Text] [Related]
12. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
13. Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway.
Rogulski K; Li Y; Rothermund K; Pu L; Watkins S; Yi F; Prochownik EV
Oncogene; 2005 Nov; 24(51):7524-41. PubMed ID: 16170375
[TBL] [Abstract][Full Text] [Related]
14. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
15. Heat shock transcription factor 1 promotes the proliferation, migration and invasion of osteosarcoma cells.
Zhou Z; Li Y; Jia Q; Wang Z; Wang X; Hu J; Xiao J
Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28370690
[TBL] [Abstract][Full Text] [Related]
16. Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants.
Chachad D; Patel LR; Recio CV; Pourebrahim R; Whitley EM; Wang W; Su X; Xu A; Lee DF; Lozano G
Cancer Res; 2023 Jul; 83(14):2297-2311. PubMed ID: 37205631
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor promotes tumor growth and metastasis in human osteosarcoma via activating STAT3.
Liu B; Lu Y; Li J; Liu Y; Liu J; Wang W
APMIS; 2015 Oct; 123(10):837-46. PubMed ID: 26271643
[TBL] [Abstract][Full Text] [Related]
18. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma.
Cam M; Gardner HL; Roberts RD; Fenger JM; Guttridge DC; London CA; Cam H
Oncotarget; 2016 Jul; 7(30):48533-48546. PubMed ID: 27391430
[TBL] [Abstract][Full Text] [Related]
19. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
Elife; 2016 Apr; 5():. PubMed ID: 27070462
[TBL] [Abstract][Full Text] [Related]
20. Integrative genome analysis of somatic p53 mutant osteosarcomas identifies Ets2-dependent regulation of small nucleolar RNAs by mutant p53 protein.
Pourebrahim R; Zhang Y; Liu B; Gao R; Xiong S; Lin PP; McArthur MJ; Ostrowski MC; Lozano G
Genes Dev; 2017 Sep; 31(18):1847-1857. PubMed ID: 29021240
[No Abstract] [Full Text] [Related]
[Next] [New Search]
